Surrogate endpoints for overall survival in locally advanced head and neck cancer: meta-analyses of individual patient data

The Lancet Oncology

Volumn 10, Issue 4, 2009, Pages 341-350

  Michiels, Stefan ^a   Le Maître, Aurélie ^a   Buyse, Marc ^b,c   Burzykowski, Tomasz ^c   Maillard, Emilie ^a   Bogaerts, Jan ^d   Vermorken, Jan B ^d   Budach, Wilfried ^d   Pajak, Thomas F ^e   Ang, Kian K ^e   Bourhis, Jean ^a   Pignon, Jean Pierre ^a  

^a INSTITUT GUSTAVE ROUSSY   (France)

^b INTERNATIONAL DRUG DEVELOPMENT INSTITUTE   (Belgium)

^c HASSELT UNIVERSITY   (Belgium)

^d EORTC DATA CENTER   (Belgium)

^e RADIATION THERAPY ONCOLOGY GROUP   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT;

ADVANCED CANCER; ARTICLE; CANCER ADJUVANT THERAPY; CANCER CONTROL; CANCER RADIOTHERAPY; CLINICAL EFFECTIVENESS; CLINICAL TRIAL; DISEASE FREE SURVIVAL; HEAD AND NECK CANCER; HUMAN; META ANALYSIS; OVERALL SURVIVAL; PRIORITY JOURNAL; SYSTEMATIC REVIEW;

ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CARCINOMA, SQUAMOUS CELL; CHEMOTHERAPY, ADJUVANT; CLINICAL TRIALS AS TOPIC; COMBINED MODALITY THERAPY; DISEASE-FREE SURVIVAL; ENDPOINT DETERMINATION; HEAD AND NECK NEOPLASMS; HUMANS; NEOPLASM RECURRENCE, LOCAL; NEOPLASM STAGING; PROGNOSIS; RADIOTHERAPY DOSAGE; RADIOTHERAPY, ADJUVANT; SURVIVAL RATE; TREATMENT OUTCOME; TUMOR MARKERS, BIOLOGICAL;

EID: 63149095503     PISSN: 14702045     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1470-2045(09)70023-3     Document Type: Article

References (114)

1. Ferlay J., Bray F., Pisani P., and Parkin D.M. GLOBOCAN 2002: cancer incidence, mortality and prevalence worldwide. IARC CancerBase, No 5, version 20 (2004), IARCPress, Lyon
2. Greenlee R.T., Murray T., Bolden S., and Wingo P.A. Cancer statistics, 2000. CA Cancer J Clin 50 (2000) 7-33
3. Berrino F., De Angelis R., Sant M., et al. Survival for eight major cancers and all cancers combined for European adults diagnosed in 1995-99: results of the EUROCARE-4 study. Lancet Oncol 8 (2007) 773-783
4. Vokes E.E., Weichselbaum R.R., Lippman S.M., and Hong W.K. Head and neck cancer. N Engl J Med 328 (1993) 184-194
5. Salama J.K., Seiwert T.Y., and Vokes E.E. Chemoradiotherapy for locally advanced head and neck cancer. J Clin Oncol 25 (2007) 4118-4126
6. Haddad R.I., and Shin D.M. Recent advances in head and neck cancer. N Engl J Med 359 (2008) 1143-1154
7. Pignon J.P., Bourhis J., Domenge C., and Designe L. Chemotherapy added to locoregional treatment for head and neck squamous-cell carcinoma: three meta-analyses of updated individual data. MACH-NC Collaborative Group. Meta-Analysis of Chemotherapy on Head and Neck Cancer. Lancet 355 (2000) 949-955
8. Pignon J.P., le Maitre A., and Bourhis J. Meta-Analyses of Chemotherapy in Head and Neck Cancer (MACH-NC): an update. Int J Radiat Oncol Biol Phys 69 2 suppl (2007) S112-S114
9. Bourhis J., Overgaard J., Audry H., et al. Hyperfractionated or accelerated radiotherapy in head and neck cancer: a meta-analysis. Lancet 368 (2006) 843-854
10. Bourhis J., Le Maitre A., Baujat B., Audry H., and Pignon J.P. Individual patients' data meta-analyses in head and neck cancer. Curr Opin Oncol 19 (2007) 188-194
11. Horiot J.C., LeFur R., N'Guyen T., et al. Hyperfractionation versus conventional fractionation in oropharyngeal carcinoma: final analysis of a randomized trial of the EORTC cooperative group of radiotherapy. Radiother Oncol 25 (1992) 231-241
12. Pinto L.H., Canary P.C., Araujo C.M., Bacelar S.C., and Souhami L. Prospective randomized trial comparing hyperfractionated versus conventional radiotherapy in stage III and IV oropharyngeal carcinoma. Int J Radiat Oncol Biol Phys 21 (1991) 557-562
13. Cummings B., O'Sullivan B., Keane T., et al. 5-year results of 4 week/twice daily radiation schedule-the Toronto trial. Radiother Oncol 56 suppl 1 (2000) S8
14. Fu K.K., Pajak T.F., Trotti A., et al. A radiation therapy oncology group (RTOG) phase III randomized study to compare hyperfractionation and two variants of accelerated fractionation to standard fractionation radiotherapy for head and neck squamous cell carcinomas: first report of RTOG 9003. Int J Radiat Oncol Biol Phys 48 (2000) 7-16
15. Horiot J.C., Bontemps P., Van Den Bogaert W., et al. Accelerated fractionation compared to conventional fractionation improves locoregional control in the radiotherapy of advanced head and neck cancer: results of the EORTC 22851 randomized trial. Radiother Oncol 44 (1997) 39-46
16. Jackson S.M., Weir L.M., Hay J.H., Tsang V.H., and Durham J.S. A randomized trial of accelerated versus conventional radiotherapy in head and neck cancer. Radiother Oncol 43 (1997) 39-46
17. Overgaard J., Hansen H.S., Specht L., et al. Five compared with six fractions per week of conventional radiotherapy of squamous-cell carcinoma of head and neck: DAHANCA 6&7 randomised controlled trial. Lancet 362 (2003) 933-940
18. Olmi P., Crispino S., Fallai C., et al. Locoregionally advanced carcinoma of the oropharynx: conventional radiotherapy versus accelerated hyperfractionated radiotherapy versus concomitant radiotherapy and chemotherapy-a multicenter randomized trial. Int J Radiat Oncol Biol Phys 55 (2003) 78-92
19. Skladowski K., Maciejewski B., Golen M., Pilecki B., Przeorek W., and Tarnawski R. Randomized clinical trial on 7-days-continuous accelerated irradiation (CAIR) of head and neck cancer-report on 3-year tumor control and normal tissue toxicity. Radiother Oncol 55 (2000) 101-110
20. Hliniak A., Gwiazdowska B., Szutkowski Z., et al. A multicenter randomized/controlled trial of a conventional versus modestly accelerated radiotherapy in the laryngeal cancer: influence of a 1 week shortening overall time. Radiother Oncol 62 (2002) 1-10
21. Marcial V.A., Pajak T.F., Chang C., Tupchong L., and Stetz J. Hyperfractionated photon radiation therapy in the treatment of advanced squamous cell carcinoma of the oral cavity, pharynx, larynx, and sinuses, using radiation therapy as the only planned modality: (preliminary report) by the Radiation Therapy Oncology Group (RTOG). Int J Radiat Oncol Biol Phys 13 (1987) 41-47
22. Dische S., Saunders M., Barrett A., Harvey A., Gibson D., and Parmar M. A randomized multicentre trial of CHART vs conventional radiotherapy in head and neck cancer. Radiother Oncol 44 (1997) 123-136
23. Dobrowsky W., and Naude J. Continuous hyperfractionated accelerated radiotherapy with/without mitomycin C in head and neck cancer. Radiother Oncol 57 (2000) 119-124
24. Poulsen M.G., Denham J.W., Peters L.J., et al. A randomised trial of accelerated and conventional radiotherapy for stage III and IV squamous carcinoma of the head and neck: a Trans-Tasman Radiation Oncology Group Study. Radiother Oncol 60 (2001) 113-122
25. Bourhis J., Lapeyre M., Tortochaux J., et al. Phase III randomized trial of very accelerated radiation therapy compared with conventional radiation therapy in squamous cell head and neck cancer: a GORTEC trial. J Clin Oncol 24 (2006) 2873-2878
26. Hussey D.H., and Abrams J.P. Combined therapy in advanced head and neck cancer: hydroxyurea and radiotherapy. Prog Clin Cancer 6 (1975) 79-86
27. Eschwege F., Sancho-Garnier H., Gerard J.P., et al. Ten-year results of a randomized trial comparing radiotherapy and concomitant bleomycin to radiotherapy alone in epidermoid carcinomas of the oropharynx: experience of the European Organization for Research and Treatment of Cancer. NCI Monograph 6 (1988) 275-278
28. Parvinen L.M., Parvinen M., Nordman E., and Kortekangas A.E. Combined bleomycin treatment and radiation therapy in squamous cell carcinoma of the head and neck region. Acta Radiol Oncol 24 (1985) 487-489
29. Vermund H., Kaalhus O., Winther F., Tausjø J., Thorud E., and Harang R. Bleomycin and radiation therapy in squamous cell carcinoma of the upper aero-digestive tract: a phase III clinical trial. Int J Radiat Oncol Biol Phys 11 (1985) 1877-1886
30. Sanchiz F., Milla A., Torner J., et al. Single fraction per day versus two fractions per day versus radiochemotherapy in the treatment of head and neck cancer. Int J Radiat Oncol Biol Phys 19 (1990) 1347-1350
31. Gupta N.K., Pointon R.C.S., and Wilkinson P.M. A randomised clinical trial to contrast radiotherapy with radiotherapy and methotrexate given synchronously in head and neck cancer. Clin Radiol 38 (1987) 575-581
32. Browman G.P., Cripps C., Hodson D.I., Eapen L., Sathya J., and Levine M. Placebo-controlled randomized trial of infusional fluorouracil during standard radiotherapy in locally advanced head and neck cancer. J Clin Oncol 12 (1994) 2648-2653
33. Haselow R.E., Warshaw M.G., Oken M.M., et al. Radiation alone versus radiation with weekly low dose cisplatinum in unresectable cancer of the head and neck. In: Fee Jr. W.R., Goepfert H., Johns M.E., et al. (Eds). Head and Neck Cancer Vol II (1990), BC Decker, Philadelphia 279-281
34. Jeremic B., Shibamoto Y., Stanisavljevic B., Miliojevic L., Milicic B., and Nikolic N. Radiation therapy alone or with concurrent low-dose daily either cisplatin or carboplatin in locally advanced unresectable squamous cell carcinoma of the head and neck: a prospective randomized trial. Radiother Oncol 43 (1997) 29-37
35. Wendt T.G., Grabenbauer G.G., Rödel C.M., et al. Simultaneous radiochemotherapy versus radiotherapy alone in advanced head and neck cancer: a randomized multicenter study. J Clin Oncol 16 (1998) 1318-1324
36. Smid L., Lesnicar H., Zakotnik B., et al. Radiotherapy, combined with simultaneous chemotherapy with mitomycin C and bleomycin for inoperable head and neck cancer: preliminary report. Int J Radiat Oncol Biol Phys 32 (1995) 769-775
37. Shanta V., and Krishnamurthi S. Combined bleomycin and radiotherapy in oral cancer. Clin Radiol 31 (1980) 617-620
38. Kapstad B., Bang G., Rennaes S., and Dhaler A. Combined preoperative treatment with cobalt and bleomycin in patients with head and neck carcinoma: a controlled clinical study. Int J Radiat Oncol Biol Phys 4 (1978) 85-89
39. Morita K. Clinical significance of radiation therapy combined with chemotherapy. Strahlentherapie 156 (1980) 228-233
40. Bezwoda W.R., de Moor N.G., and Derman D. Treatment of advanced head and neck cancer by means of radiation plus chemotherapy: a randomised trial. Med Pediatr Oncol 6 (1979) 353-358
41. Nissenbaum M., Browde S., Bezwoda W., de Moor N.G., and Derman D.P. Treatment of advanced head and neck cancer: multiple daily dose fractionated radiation therapy and sequential multimodal treatment approach. Med Pediatr Oncol 12 (1984) 204-208
42. Weissberg J.B., Son Y.H., Papac R.J., et al. Randomized clinical trial of mitomycin C as an adjunct to radiotherapy in head and neck cancer. Int J Radiat Oncol Biol Phys 17 (1989) 3-9
43. Bachaud J.M., Cohen-Jonathan E., Alzieu C., David J.M., Serrano E., and Daly-Schveitzer N. Combined postoperative radiotherapy and weekly cisplatin infusion for locally advanced head and neck carcinoma: final report of a randomized trial. Int J Radiat Oncol Biol Phys 36 (1996) 999-1004
44. Keane T.J., Cummings B.J., O'Sullivan B., et al. A randomized trial of radiation therapy compared to split course radiation therapy combined with mitomycin C and 5 fluorouracil as initial treatment for advanced laryngeal and hypopharyngeal carcinoma. Int J Radiat Oncol Biol Phys 25 (1993) 613-618
45. Haffty B.G., Son Y.H., Sasaki C.T., et al. Mitomycin C as an adjunct to postoperative radiation therapy in squamous cell carcinoma of the head and neck: results from two randomized clinical trials. Int J Radiat Oncol Biol Phys 27 (1993) 241-250
46. Weissler M.C., Melin S., Sailer S.L., et al. Simultaneous chemoradiation in the treatment of advanced head and neck cancer. Arch Otolaryngol Head Neck Surg 118 (1992) 806-810
47. Merlano M., Vitale V., Rosso R., et al. Treatment of advanced squamous cell carcinoma of the head and neck with alternating chemotherapy and radiotherapy. N Engl J Med 327 (1992) 1115-1121
48. Salvajoli J.V., Morioka H., Trippe N., and Kowalski L.P. A randomized trial of neoadjuvant vs concomitant chemotherapy vs radiotherapy alone in the treatment of stage IV head and neck squamous cell carcinoma. Eur Arch Otorhinolaryngol 249 (1991) 211-215
49. Kumar S., Datta N.R., Ahuja R.C., Mali H.R., Agarwal G.N., and Ayyagari S. Feasibility of non-cisplatin-based induction chemotherapy and concurrent chemoradiotherapy in advanced head and neck cancer. Acta Oncologica 35 (1996) 721-725
50. Adelstein D.J., Lavertu P., Saxton J.P., et al. Mature results of a phase III randomized trial comparing concurrent chemoradiotherapy with radiotherapy alone in patients with stage III and IV squamous cell carcinoma of the head and neck. Cancer 88 (2000) 876-883
51. Brizel D.M., Albers M.E., Fisher S.R., et al. Hyperfractionated irradiation with or without concurrent chemotherapy for locally advanced head and neck cancer. N Engl J Med 338 (1998) 1798-1804
52. Tobias J.S., Monson K.M., Glaholm J., et al. UKHAN-1: A prospective multi-centre randomised trial investigating chemotherapy as part of initial management in advanced head and neck cancer. Rad Oncol 58 suppl 1 (2001) S16
53. Jeremic B., Shibamoto Y., Milicic B., et al. Hyperfractionated radiotherapy with or without concurrent low-dose daily cisplatin in locally advanced squamous cell carcinoma of the head and neck: a prospective randomized trial. J Clin Oncol 18 (2000) 1458-1464
54. Giglio R., Mickiewicz E., Pradier R., et al. No reccurence beyond the second year of follow-up in inoperable stage III and IV squamous cell carcinoma of the head and neck patients (IOHN). Final report of a randomized trial of alternating chemotherapy (CT) + hyperfractionated radiotherapy (RT) vs RT alone. Proc Am Soc Clin Oncol 15 (1999) 317
55. Corvo R., Corvo R., Sanguineti G., et al. Alternating chemo-radiotherapy versus partly accelerated radiotherapy in locally advanced squamous cell carcinoma of the head and neck: results of a phase III randomized trial. Cancer 92 (2001) 2856-2867
56. Adelstein D.J., Li Y., Adams G.L., et al. A intergroup phase III comparison of standard radiotherapy therapy and two schedules concurrent chemoradiotherapy in patients with unresectable squamous cell head and neck cancer. J Clin Oncol 21 (2003) 92-98
57. Forastiere A.A., Goepfert H., Maor M., et al. Concurrent chemotherapy and radiotherapy for organ preservation in advanced laryngeal cancer. N Engl J Med 349 (2003) 2091-2098
58. Denis F., Garaud P., Bardet E., et al. Final results of 94-01 French Head and Neck Oncology and Radiotherapy Group randomized trial comparing radiotherapy alone with concomitant radio chemotherapy in advanced-stage oropharynx carcinoma. J Clin Oncol 22 (2004) 69-76
59. Budach V., Stuschke M., Budach W., et al. Hyperfractionated accelerated chemoradiation with concurrent fluorouracil-mitomycin is more effective than dose-escalated hyperfractionated accelerated radiation therapy alone in locally advanced head and neck cancer: final results of the radiotherapy cooperative clinical trials group of the German cancer society 95-06 prospective randomized trial. J Clin Oncol 23 (2005) 1125-1135
60. Bernier J., Domenge C., Ozsahin M., et al. Postoperative irradiation with or without concomitant chemotherapy for locally advanced head and neck carcinomas. N Engl J Med 350 (2004) 1945-1952
61. Huguenin P., Beer K.T., Allal A., et al. Concomitant cisplatin significantly improves locoregional control in advanced head and neck cancers treated with hyperfractionated radiotherapy. J Clin Oncol 22 (2004) 4665-4673
62. Staar S., Rudat V., Stuetzer H., et al. Intensified hyperfractionated accelerated radiotherapy limits the additional benefit of simultaneous chemotherapy - Results of a multicentric randomized German trial in advanced head and neck (HN) cancer. Int J Radiat Oncol Biol Phys 50 (2001) 1161-1171
63. Fountzilas G., Ciuleanu E., Dafni U., et al. Concomitant radio chemotherapy vs radiotherapy alone in patients with head and neck cancer: a Hellenic Cooperative Oncology Group Phase III Study. Med Oncol 21 (2004) 95-107
64. Cooper J.S., Pajak T.F., Forastiere A.A., et al. Postoperative concurrent radio-chemotherapy in high-risk squamous-cell carcinoma of the head and neck. N Engl J Med 350 (2004) 1937-1944
65. Grau C., Prakash Agarwal J., Jabeen K., et al. Radiotherapy with or without mitomycin c in the treatment of locally advanced head and neck cancer: results of the IAEA multicentre randomised trial. Rad Oncol 67 (2003) 17-26
66. Bourhis J., Lapeyre M., Tortochaux J., et al. Very accelerated radiotherapy versus CDDP-5FU in unresectable HNSCC: results of the GORTEC 96-01 randomized trial. Radiother Oncol 64 suppl 1 (2002) S118
67. Lartigau E.F., Giralt J., Glassman P., Lawton A., and von Roemeling R. A phase IIII double-blind randomized placebo controlled study of porfiromycin and radiation therapy in patients with head and neck cancer. Int J Rad Oncol Biol Phys 54 suppl (2003) 74
68. Zakotnik B., Budihna M., Smid L., et al. Patterns of failure in patients with locally advanced head-and neck cancer treated postoperatively with irradiation or concomitant irradiation with mitomycin C and bleomycin. Int J Radiat Oncol Biol Phys 67 (2007) 685-690
69. Toohill R.J., Anderson T., Byhardt R.W., et al. Cisplatin and Fluorouracil as neoadjuvant therapy in head and neck cancer: a preliminary report. Arch Otolaryngol Head Neck Surg 113 (1987) 758-761
70. Lewin F., Damber L., Jonsson H., et al. Neoadjuvant chemotherapy with cisplatin and 5-fluorouracil in advanced squamous cell carcinoma of the head and neck: a randomized phase III study. Radiother Oncol 43 (1997) 23-28
71. Martin M., Vergnes L., Lelièvre G., et al. A randomized study of CDDP and 5-FU as neoadjuvant chemotherapy in head and neck cancer: an interim analysis. In: Banzet P., Holland J.F., Khayat D., and Weil M. (Eds). Cancer treatment: an update (1994), Springer-Verlag, Paris 214-218
72. Paccagnella A., Orlando A., Marchiori C., et al. Phase III trial of initial chemotherapy in stage III or IV head and neck cancers: a study by the Gruppo di Studio sui Tumori della Testa e del Collo. J Natl Cancer Inst 86 (1994) 265-272
73. Domenge C., Lancar R., Coche-Dequean B., et al. Induction chemotherapy before radiotherapy in oropharyngeal carcinoma: a randomized trial. Eur J Cancer 31A suppl 5 (1995) S86
74. Domenge C., Hill C., Lefebvre J.L., et al. Randomized trial of neoadjuvant chemotherapy in oropharyngeal carcinoma. French Groupe d'Etude des Tumeurs de la Tête et du Cou (GETTEC). Br J Cancer 83 (2000) 1594-1598
75. Dalley D., Beller E., Aroney R., et al. The value of chemotherapy (CT) prior to definitive local therapy (DTL) in patients with locally advanced squamous cell carcinoma (SCC) of the head and neck (HN). Proc Am Soc Clin Oncol 14 (1995) 297
76. Tejedor M., Murias A., Soria P., et al. Induction chemotherapy with carboplatin and ftoratur in advanced head and neck cancer: a randomized study. Am J Clin Oncol 15 (1992) 417-421
77. Gedouin D., Desprez P., Perron J.J., et al. Cancers de la base de langue et de l'hypopharynx: résultats d'un essai multicentrique randomisé de chimiothérapie avant traitement locorégional. Bull Cancer/Radiother 83 (1996) 104-107
78. Di Blasio B., Barbieri W., Bozzetti A., Lotti C., Di Sarra S., and Cocconi G. A prospective randomized trial in resectable head and neck carcinoma: loco-regional treatment with and without neoadjuvant chemotherapy. Proc Am Soc Clin Oncol 13 (1994) 279
79. Depondt J., Gehanno P., Martin M., et al. Neoadjuvant chemotherapy with carboplatin/5-fluorouracil in head and neck cancer. Oncology 50 (1993) 23-27
80. Volling P., Schröder M., Müller R.P., Ebeling O., Quirin R., and Stennert E. Induction chemotherapy in primary resectable head and neck tumors: a prospective randomized trial. Int J Oncol 4 (1994) 909-914
81. Hasegawa Y., Matsuura H., Fukushima M., Kano M., and Shimozato K. Potential suppression of distant and node metastasis by neoadjuvant chemotherapy in advanced head and neck cancer: result of a randomized trial. Proc Am Soc Clin Oncol 15 (1996) 318
82. Richard J.M., Sancho H., Lepintre Y., et al. Intra-arterial methotrexate chemotherapy and telecobalt therapy in cancer of the oral cavity and oropharynx. Cancer 34 (1974) 491-496
83. Fazekas J.T., Sommer C., Kramer S., et al. Adjuvant intravenous methotrexate or definitive radiotherapy alone for advanced squamous cancers of the oral cavity, oropharynx, supraglottic larynx or hypopharynx: concluding report of an RTOG randomized trial on 638 patients. Int J Radiat Oncol Biol Phys 6 (1980) 533-541
84. Jortay A., Demard F., Dalesio O., et al. A randomized EORTC study on the effect of preoperative polychemotherapy in pyriform sinus carcinoma treated by pharyngolaryngectomy and irradiation. Results from 5 to 10 years. Acta Chir Belg 90 (1990) 115-122
85. Pearlman N.W., Johnson F.B., Braun T.J., et al. A prospective study of preoperative chemotherapy and split-course irradiation for locally advanced and recurrent oral/pharyngeal squamous carcinoma. Am J Clin Oncol 8 (1985) 490-496
86. The Head and Neck Contracts Program. Adjuvant chemotherapy for advanced head and neck squamous carcinoma: final report of the Head and Neck Contracts Program. Cancer 60 (1987) 301-311
87. Richard J.M., Kramar A., Molinari R., et al. Randomized EORTC head and neck cooperative group trial of preoperative intra-arterial chemotherapy in oral cavity and oropharynx carcinoma. Eur J Cancer 27 (1991) 821-827
88. Holoye P.Y., Grossman T.W., Toohill R.J., et al. Randomized study of adjuvant chemotherapy for head and neck cancer. Otolaryngol Head Neck Surg 93 (1985) 712-717
89. Schuller D.E., Metch B., Stein D.W., et al. Preoperative chemotherapy in advanced resectable head and neck cancer: final report of the South West Oncology Group. Laryngoscope 98 (1988) 1205-1211
90. Szpirglas H., Nizri D., Marneur M., et al. Neoadjuvant chemotherapy. A randomized trial before radiotherapy in oral and oropharyngeal carcinomas: end results. Proceedings of the 2nd international head and neck oncology research conference (1988), Kugler Publications, and Amsterdam, Milano, Ghedini Editore, Berkeley 261-264
91. Carugati A., Pradier R., and de la Torre A. Combination chemotherapy pre-radical treatment for head and neck squamous cell carcinoma. Proc Am Soc Clin Oncol 7 (1988) 152
92. Mazeron J.J., Martin M., Brun B., et al. Induction chemotherapy in head and neck cancer results of a phase III trial. Head Neck 14 (1992) 85-91
93. Brunin F., Rodriguez J., Jaulery C., et al. Induction chemotherapy in advanced head and neck cancer: preliminary results of a randomized study. Acta Oncol 28 (1989) 61-65
94. Jaulerry C., Rodriguez J., Brunin F., et al. Induction chemotherapy in advanced head and neck tumors results of two randomised trials. Int J Radiat Oncol Biol Phys 23 (1992) 483-489
95. Maipang T., Maipang M., Geater A., Panjapiyakul C., Watanaarepornchai S., and Punperk S. Combination chemotherapy as induction therapy for advanced resectable head and neck cancer. J Surg Oncol 59 (1995) 80-85
96. Domenge C., Marandas P., Vignoud J., et al. Post-surgical adjuvant chemotherapy in extracapsular spread invaded lymph node (N+R+) of epidermoid carcinoma of the head and neck: a randomized multicentric trial. Am Soc Head Neck Surg 74 (1988) (abstr).
97. Kotani A., Sunada O., Tamura M., et al. Multiple cooperative study of UFT-adjuvant chemotherapy for malignant tumor in the jaw and oral cavities. Gan To Kagaku Ryoho 21 (1994) 987-992
98. Laramore G.E., Scott C.B., Al-Sarraf M., et al. Adjuvant chemotherapy for resectable squamous cell carcinomas of the head and neck: report on Intergroup study 0034. Int J Radiat Oncol Biol Phys 23 (1992) 705-713
99. Rao R.S., Parikh D.M., Parikh H.K., Bhansali M.B., Deshmane V.H., and Fakih A.R. Perioperative chemotherapy in patients with oral cancer. Am J Surg 168 (1994) 262-267
100. Szpirglas H., Chastang C., and Bertrand J.C. Adjuvant treatment of tongue and floor of the mouth cancers. In: Bonadonna G., Mathé G., and Salmon S.E. (Eds). Adjuvant therapies and markers of post-surgical minimal residual disease II. Adjuvant therapies of the various primary tumors (1979), Springer Verlag, Berlin 309-317
101. Tsukuda M., Ogasawara H., Kaneko S., et al. A prospective randomized trial of adjuvant chemotherapy with UFT for head and neck carcinoma. Head and Neck UFT Study Group. Gan To Kagaku Ryoho 21 (1994) 1169-1177
102. Yoshino K., Sato T., Nakai Y., et al. A comparative clinical study of adjuvant chemotherapy for tumors in the head and neck area by means of HCFU. Gan To Kagaku Ryoho 18 (1991) 2581-2588
103. Buyse M., Molenberghs G., Burzykowski T., Renard D., and Geys H. The validation of surrogate endpoints in meta-analyses of randomized experiments. Biostatistics 1 (2000) 49-67
104. Buyse M., Burzykowski T., Michiels S., and Carroll K. Individual- and trial-level surrogacy in colorectal cancer. Stat Methods Med Res 17 (2008) 467-565
105. Burzykowski T., Molenberghs G., Buyse M., Geys H., and Renard D. Validation of surrogate end points in multiple randomized clinical trials with failure time end points. J R Stat Soc Ser C-Appl Stat 50 (2001) 405-422
106. Burzykowski T., Molenberghs G., and Buyse M. The evaluation of surrogate endpoints. Statistics for biology and health (2005), Springer, New York 408
107. Julious S.A., Campbell M.J., and Walters S.J. Predicting where future means will lie based on the results of the current trial. Contemp Clin trials 28 (2007) 352-357
108. Burzykowski T., and Buyse M. Surrogate threshold effect: an alternative measure for meta-analytic surrogate endpoint validation. Pharm Stat 5 (2006) 173-186
109. Prentice R.L. Surrogate endpoints in clinical trials: definition and operational criteria. Stat Med 8 (1989) 431-440
110. Sargent D.J., Wieand H.S., Haller D.G., et al. Disease-free survival versus overall survival as a primary end point for adjuvant colon cancer studies: individual patient data from 20,898 patients on 18 randomized trials. J Clin Oncol 23 (2005) 8664-8670
111. Buyse M., Burzykowski T., Carroll K., et al. Progression-free survival is a surrogate for survival in advanced colorectal cancer. J Clin Oncol 25 (2007) 5218-5224
112. Burzykowski T., Buyse M., Piccart-Gebhart M.J., et al. Evaluation of tumor response, disease control, progression-free survival, and time to progression as potential surrogate end points in metastatic breast cancer. J Clin Oncol 26 (2008) 1987-1992
113. Buyse M., Squifflet P., Laporte S., et al. Prediction of survival benefits from progression-free survival in patients with advanced non small cell lung cancer: evidence from a pooled analysis of 2,838 patients randomized in 7 trials. J Clin Oncol 26 suppl (2008) abstr 8019.
114. Bonner J.A., Harari P.M., Giralt J., et al. Radiotherapy plus cetuximab for squamous-cell carcinoma of the head and neck. N Engl J Med 354 (2006) 567-578